Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Opinion & Analysis State Street Health Care Select Sector SPDR ETF XLV

The Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. The fund invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care sectors. It invests in growth and value stocks of companies across... see more

Opinion & Analysis (ARCA:XLV)

Facial Skincare and Anti-Aging Trends and Investment Opportunities for 2017 and Beyond

V. David Ben Melech August 3, 2017

Major funds betting on Trump sector

The Life Sciences Report February 28, 2017

Investing in life sciences under the Trump presidency

The Life Sciences Report February 17, 2017

Regeneus hits the fast track with major Japanese partnership

The Life Sciences Report February 9, 2017

Reliable contrarian indicator says stocks could rise 25%

Chris Ciovacco December 5, 2016

US election’s impact on marijuana stocks

Vin Maru November 8, 2016

Exploring solutions to healthcare's spending crisis

The Life Sciences Report October 19, 2016

Stock-moving catalysts anticipated for Regeneus in Q4/16

The Life Sciences Report September 30, 2016

It feels like inflation

Gary Tanashian  May 26, 2016

Advanced Stem Cell Manufacture Saves Lives and Prints Money: Stewart Washer of Cynata Therapeutics

The Life Sciences Report February 4, 2016

Look North for Value-Priced Growth in Healthcare: StoneCastle's Bruce Campbell

The Life Sciences Report February 3, 2016

Immunotherapy Inside the Cell: Three Companies on Their Way to the 'Holy Grail' of Cancer Treatment

The Life Sciences Report January 6, 2016

Regenerative Medicine Follows the CAR T-Cell Gravy Train: Maxim Group's Jason Kolbert and Jason McCarthy

George S. Mack December 3, 2015

Healthcare Humbled, But Not Knocked Out

Benzinga.com  October 10, 2015

Sector SPDRs Pare Fees

Benzinga.com  October 9, 2015

Overweight A Struggling Energy ETF? One Research Firm Says Yes

Benzinga.com  October 7, 2015

Going Shopping With Consumer Discretionary ETFs

Benzinga.com  October 6, 2015

Seasonality Says These Sector ETFs Could Work In October

Benzinga.com  September 30, 2015

Small-Cap Healthcare ETF: A Baby Thrown Out With The Bathwater

Benzinga.com  September 29, 2015

ETFs Are Bigger Than Hedge Funds And Hedge Funds Are A Big Reason Why

Benzinga.com  September 22, 2015